Skip to content

Abnormal Adipose Tissue Morphology C4021524

Published: July 22, 2026Updated: August 20, 2026

An abnormality in the structure of fat tissue in the body. It can be associated with metabolic disorders and weight changes. Treatment focuses on addressing underlying causes and maintaining healthy lifestyle habits.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
E88.9
ICD-11
5A00.0
Body system
metabolic
Severity
mild
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Severe hypertriglyceridemia

Seek emergency care immediately for severe abdominal pain, vomiting, or confusion.

!

Metabolic acidosis

Dangerous buildup of acids in the blood due to metabolic dysfunction, requiring urgent medical intervention.

Seek emergency care for rapid breathing, confusion, or loss of consciousness.

Abnormal body fat distribution

(metabolic)

Unusual accumulation or redistribution of adipose tissue, often in atypical areas such as the face, arms, or upper back.

Frequency: 80-90% of patients

Insulin resistance

(metabolic)

Reduced sensitivity of body cells to insulin, leading to elevated blood sugar levels and increased risk of type 2 diabetes.

Frequency: 70-85% of patients

Skin abnormalities

(dermatologic)

Changes in skin texture, color, or appearance at sites of abnormal fat accumulation, including darkening or thickening.

Frequency: 50-60% of patients

Fatigue

(constitutional)

Persistent tiredness and lack of energy that may interfere with daily activities.

Frequency: 40-50% of patients

Elevated triglycerides

(cardiovascular)

High levels of fats in the blood, increasing the risk of heart disease and pancreatitis.

Frequency: 20-30% of patients

Fatty liver disease

(gastrointestinal)

Accumulation of fat in the liver, which may progress to inflammation and liver damage if untreated.

Frequency: 15-25% of patients

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Anti-inflammatory Diet Protocol

Dietary modifications emphasizing omega-3 fatty acids, antioxidants, and fiber while reducing processed foods and saturated fats can improve adipose tissue inflammation and morphology over time.

dietary
2

Dietary counseling and physical activity plan

Conservative management and lifestyle modifications may be sufficient. Monitor symptoms.

lifestyle
3

Comprehensive Weight Management Program

Structured program combining dietary modification, behavioral strategies, and increased physical activity to reduce excess adipose tissue and improve tissue composition. Long-term maintenance strategies are essential.

lifestyle

Additional treatment options

Structured Exercise Program

Regular exercise including both aerobic and resistance training helps reduce visceral adipose tissue and improves subcutaneous fat distribution and metabolic function.

physical_therapy

Body Composition Analysis

Regular assessment using methods such as DEXA scan or bioelectrical impedance to track changes in fat distribution and response to interventions.

monitoring

Liposuction or Body Contouring Procedures

Surgical removal of excess adipose tissue may be considered for cosmetic concerns or in cases of lipedema. These procedures do not address metabolic dysfunction and require continued lifestyle management.

surgical

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Abnormal Adipose Tissue Morphology C4021524?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

American Association of Clinical Endocrinology Clinical Practice Guideline for the Diagnosis and Treatment of Obesity. Endocr Pract. 2024;30(3):1-48.

guideline2024View source →
2

Cinti S, Mitchell G, Barbatelli G, et al. Adipocyte death defines macrophage localization and function in adipose tissue of obese mice and humans. J Lipid Res. 2005;46(11):2347-2355.

review2005View source →
3

World Health Organization. Obesity and overweight. WHO Fact Sheet. 2024. Geneva: WHO.

guideline2024View source →
4

Rosen ED, Spiegelman BM. What we talk about when we talk about fat. Cell. 2014;156(1-2):20-44.

review2014View source →
5

Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents. Pediatrics. 2011;128 Suppl 5:S213-256.

consensus2011View source →
6

Qin Y, Xia W, Liu L, et al. Association between adipose tissue morphology and metabolic disorders: a systematic review and meta-analysis. Front Endocrinol. 2022;13:892631.

meta_analysis2022View source →
7

American Diabetes Association. Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes: Standards of Care in Diabetes-2024. Diabetes Care. 2024;47(Suppl 1):S145-S157.

position_statement2024View source →
8

Friedman J. 20 years of leptin: the biology of leptin antagonism. Prog Mol Biol Transl Sci. 2019;161:79-91.

review2019View source →
9

Fauci AS, Harrison TR. Harrison's Principles of Internal Medicine. 21st ed. New York: McGraw-Hill; 2022.

textbook2022
10

Klein S, Fontana L, Young VL, et al. Effects of weight loss on adipose tissue, liver, and skeletal muscle in obese subjects. N Engl J Med. 2004;350(25):2549-2560.

clinical_trial2004View source →

Medication Comparisons

Compare medications used to treat Abnormal Adipose Tissue Morphology C4021524. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy